# A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia

> **NCT03600909** · PHASE2 · TERMINATED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Fanconi Anemia
- Myelodysplastic Syndrome (MDS)
- Acute Myelogenous Leukemia (AML)

## Interventions

- **DRUG:** Busulfan
- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide
- **DRUG:** Anti-Thymocyte Globulin (Rabbit)
- **DEVICE:** The CliniMACS device
- **DRUG:** G-CSF

## Key facts

- **NCT ID:** NCT03600909
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-15
- **Primary completion:** 2021-04-09
- **Final completion:** 2021-04-09
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Accrual has been slow
- **Last updated:** 2022-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03600909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03600909, "A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03600909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*